Stock listing

Illumina, Inc.

Selected listing: 927079 · LSX · EUR · DE

Illumina, Inc. (LS Exchange: 927079), Health Technology. Latest release Sep 17, 2026: illumine Ushers in a New Era of Childcare AI with its Latest Launch…

927079:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: 927079
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LS Exchange
Currency: EUR

About Illumina, Inc.

Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.

Latest news from Illumina, Inc.

illumine Ushers in a New Era of Childcare AI with its Latest Launch at illumine NEXT

September 17, 2026

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

July 30, 2026

Illumina expands Billion Cell Atlas program with new AI drug developers

July 16, 2026

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

July 9, 2026

Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

July 9, 2026

All Illumina, Inc. news →

Events

Replays

Illumina, Inc. (ILMN) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 04:30 PM ET
Watch
Illumina, Inc. (ILMN) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
Illumina, Inc. (ILMN) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 04:30 PM ET
Watch

Research Illumina, Inc.

Illumina, Inc. company profile

View the public company page for Illumina, Inc. on 6ix.

Illumina, Inc. news

Read company news and market updates connected to Illumina, Inc..

Illumina, Inc. investor events

Find investor webinars, events, and replay context for Illumina, Inc..